Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience. uri icon

authors

  • Dholaria, Bhagirathbhai
  • Oluwole, Olalekan O
  • Mehraban, Nasima
  • Baer, Brittney
  • Long, Nancy
  • Reena Jayani, MD, MSCI
  • Byrne, Michael T
  • Kassim, Adetola A
  • Engelhardt, Brian G
  • Savani, Bipin N

publication date

  • January 1, 2022